These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1175465)

  • 1. An open study of mesoridazine (Serentil) in chronic schizophrenics.
    Aguilar SJ
    Dis Nerv Syst; 1975 Sep; 36(9):484-9. PubMed ID: 1175465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.
    Freeman H
    Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesoridazine (Serentil) in personality disorders--a controlled trial in adolescent patients.
    Barnes RJ
    Dis Nerv Syst; 1977 Apr; 38(4):258-64. PubMed ID: 321198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK; Ungvari GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Ratner Y; Gibel A; Yorkov V; Ritsner MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1401-9. PubMed ID: 17669574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response to clozapine treatment of 11 chronic patients in a state psychiatric hospital.
    Herman M
    Aust N Z J Ment Health Nurs; 1997 Sep; 6(3):129-33. PubMed ID: 9384012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acutely ill schizophrenic patients treated with loxapine. A clinical study in a community mental health center.
    Rasul M
    Clin Ther; 1980; 3(4):242-9. PubMed ID: 7273062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of thiothixene in chronic schizophrenia. A double-blind controlled trial.
    Burnett GB; Little SR; Graham N; Forrest AD
    Dis Nerv Syst; 1975 Nov; 36(11):625-9. PubMed ID: 1102277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiatsu as an adjuvant therapy for schizophrenia: an open-label pilot study.
    Lichtenberg P; Vass A; Ptaya H; Edelman S; Heresco-Levy U
    Altern Ther Health Med; 2009; 15(5):44-6. PubMed ID: 19771930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open clinical study of cis(Z)-clopenthixol.
    Sechter D; Caillard V; Cuche H; Deniker P
    Acta Psychiatr Scand Suppl; 1981; 294():20-4. PubMed ID: 6951393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risperidone in the treatment of acute exacerbation of schizophrenia symptoms].
    Gutiérrez M; Gibert J; Bobes J; Herráiz ML; Fernández A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(2):83-9. PubMed ID: 9595821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clozapine and refractory schizophrenia. Long-term prospective study of 20 patients].
    Jalenques I; Coudert AJ
    Encephale; 1994; 20(6):767-75. PubMed ID: 7875111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
    György B; Robert K; László C; Andrea J;
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen in the treatment of schizophrenia: a pilot study.
    Schöpf J; Hucker H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):89-91. PubMed ID: 360234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.